These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30015959)

  • 1. Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
    Ji Y; Jiang Q; Jian G; Sun H; Wang Y; Qin H; Zhang S; Cao J; Tang Z
    Oncol Rep; 2018 Sep; 40(3):1695-1705. PubMed ID: 30015959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
    Tang Z; Zeng Q; Li Y; Zhang X; Ma J; Suto MJ; Xu B; Yi N
    Oncotarget; 2017 Apr; 8(16):27428-27439. PubMed ID: 28404969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
    Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
    Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
    Tanić M; Krivokuća A; Čavić M; Mladenović J; Plesinac Karapandžić V; Beck S; Radulović S; Susnjar S; Janković R
    Radiat Oncol; 2018 Oct; 13(1):193. PubMed ID: 30285791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of radiosensitive patients with gastric cancer by developing gene signature.
    Zhou J; Wu X; Li G; Gao X; Zhai M; Chen W; Hu H; Tang Z
    Int J Oncol; 2017 Oct; 51(4):1067-1076. PubMed ID: 28902346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
    Tang Z; Zeng Q; Li Y; Zhang X; Suto MJ; Xu B; Yi N
    Oncol Rep; 2017 Nov; 38(5):2814-2824. PubMed ID: 29048650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.
    Bernichon E; Vallard A; Wang Q; Attignon V; Pissaloux D; Bachelot T; Heudel PE; Ray-Coquard I; Bonnet E; de la Fouchardière A; Faure C; Chopin N; Beurrier F; Racadot S; Sunyach MP; Rancoule C; Perol D; Corset V; Agrapart V; Tinquaut F; Blay JY; Magné N; Trédan O
    Ann Oncol; 2017 Nov; 28(11):2773-2779. PubMed ID: 28945826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
    Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
    Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Jang BS; Kim IA
    Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
    Cui Y; Li B; Pollom EL; Horst KC; Li R
    Clin Cancer Res; 2018 Oct; 24(19):4754-4762. PubMed ID: 29921729
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
    Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
    Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
    Tao C; Luo R; Song J; Zhang W; Ran L
    J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway.
    Meng J; Li P; Zhang Q; Yang Z; Fu S
    Oncotarget; 2014 Jul; 5(13):4683-93. PubMed ID: 24970813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer Patients.
    Bosma SCJ; Hoogstraat M; van der Leij F; de Maaker M; Wesseling J; Lips E; Loo CE; Rutgers EJ; Elkhuizen PHM; Bartelink H; van de Vijver MJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):174-181. PubMed ID: 31525407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
    Wolf B; Goebel G; Hackl H; Fiegl H
    BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
    Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.
    Corvò R; Ricchetti F; Doino D; Torielli P; Agostinelli S; Cavagnetto F; Giannelli F; D'Alonzo A; Vagge S; Belgioia L; Guenzi M
    Anticancer Res; 2010 Nov; 30(11):4749-53. PubMed ID: 21115935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of in situ carcinoma of the breast. EORTC Breast Group].
    Julien JP
    Praxis (Bern 1994); 1998 Apr; 87(15):520-3. PubMed ID: 9608248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.